Active Funds

American Cannabis Distribution Fund 

Investment Thesis:

The purpose of this fund is creating a multifaceted vertically integrated distribution structure across the United States to facilitate the cannabis THC and Cannabis or hemp CBD. Clientele capital management group already controls as well as merger acquisition activity through licensed and unlicensed entities throughout the United States in North America.

We will accomplish the goal of creating a distribution network by segregating different business aspects into different sub sacks. More specifically creating different silos for the licensed entities and the entities that do not need specific cannabis licensing.

>>>>>Get qualified for full prospectus<<<<<<<<<<

Fund Size: $50,000,000

Minimum Investment: $100,000

Funding Period: June 1, 2018 – May 31, 2019

Hurdle Rate: 12%

Carried Interest: 30%

Fund Term: 5-7 Years /(this may be changed later if we go with an evergreen fund)

Cliintel Capital Aggressive Growth Fund IV

Investment Thesis:

We have invested in various major functions of the industry to create a first of its kind vertically conglomerate of symbiotic cannabis companies that are licensed legally through the fund with the Marijuana Enforcement Division of Colorado. This is the first time in the United States that this type of license has been issued, allowing our outside investors to own equity in licensed businesses while remaining passive unlicensed investors.  
This structure allows us to offer investors a globally unique opportunity to invest in a diversified, professionally- managed venture capital fund without having direct licensing exposure to the cannabis industry. Further, federal legislative climate creates an asymmetrical risk to return profile with potential for multipliers
 
 We work to exploit those rifts in legislation and the burgeoning billion dollar industry in the US and abroad. We currently are running operations in CA, NV, CO, AZ, WA, MI, and OR. We are poised to control a large portion of the distribution of Cannabis in North America.

Portfolio: 

5156 Systems – Equipment and Real Estate Leasing
ESCAPE – Provides packaging, hardware, terpenes to all CLEAR licensees across 8 states
SUBTLE RELIEF The CLEAR CBD line of cartridges and CBD isolate
BONSAI Cultivation 35,000 sq/ft Recreational Grow Facility
Clear Colorado Group – The CLEAR distillate licensee in Colorado
Vita-Meds – 2 Med/Rec Grow facilities, one Marijuana Infused Products lab and 1 dispensary
CARTA Carta is a Private Equity and Venture Capital owner management system employed by some of the top firms in the country. CARTA allows our investors to see their portfolio in real time at any time.

Cliintel Capital Aggressive Growth Fund V

Executive Summary:

We invest in major functions of the cannabis industry to create a vertically integrated ecosystem of companies that can be scaled,
consolidated and function at national levels, across state lines. We have funded, bought or created the pieces and processes
required to control the distribution of THC & CBD.

We operate an ecosystem of companies, funded by a blind pool private investment grade fund instrument. We are poised to become
the first firm to receive a Qualified Institutional Investor designation issued in the State of Colorado allowing a fund to hold licensed
entities. Our private equity structure allows a unique opportunity to invest into a professionally- managed venture capital fund that
holds minority interest in existing licensees. This allows us to provide liquidity to successful operators, something no other firm can
currently offer.

The Federal legislative climate has created an asymmetrical risk to return profile with potential for exit multipliers exceeding 10x. We
work to exploit rifts in legislation around the multi-billion dollar cannabis industry in the US and abroad. We are currently operating
in seven states (CA, NV, CO, AZ, WA, MI, and OR). We are positioned to control a large portion of the distribution of Cannabis in
North America through capital raise of initial public offerings and/or the continuation of private capital raises.
CCMG’s assets include: a distribution company, a compliance and regulatory consultancy, 75,000sq/ft in combined medical/ recreational grow facilities, 2 Marijuana Infused Products labs, a medical CBD only line capable of international distribution, the best-
known extraction brand in the country (The CLEAR), a patented vaping hardware line that is integrated with our extracts into a marketing and distribution sales effort.

CCMG Today:

1. We have processes and systems ready to be scaled to all operations, built for heavy volume and currently operational in Colorado.
The ‘American Cannabis Distribution Company’ will control distribution across the United States through the utilization of
infrastructure assets managed by Fund IV (our active infrastructure fund).

2. CCMG controls one of the most famous brand names in Cannabis concentrates today (The CLEAR), one of a handful of brands that are in more than one state. Our captive brands related to marijuana-infused products, the labs to produce those products, supplier
relationships to feed raw material into the labs, consumer consumption hardware supplier agreements in which the infused products
are placed and finally the distribution networks that handle the wholesale activity surrounding sales, support delivery, and
collection services.

3. CCMG’s management team has the financial and business expertise outside of the cannabis industry along with a proven track
record inside the cannabis space which is second to none in private equity. CCMG is seeking $65MM as the targeted capital raise,
detailed business plans, sources/uses and further information will be provided to prospective investors.

Contact

7979 E Tufts Ave
Ste. 1100
Denver, CO 80014

303.495.2101
rick@cliintel.com